$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The latest price and purchasing reference information of Pimitespib in 2025
2026-02-01 22:25:32
Check Details
Comparison of the efficacy and side effects of afatinib (Gitarel) and dacomitinib
2026-02-01 22:25:32
Check Details
Analysis of the mechanism of action and clinical pharmacological properties of DaliRasheng (Keweike)
2026-02-01 22:25:32
Check Details
What is garadacimab-ANDEMBRY a drug for?
2026-02-01 22:25:32
Check Details
What is the correct use of Trientine?
2026-02-01 22:25:32
Check Details
How much does a box of mirikizumab cost? Market reference
2026-02-01 22:25:32
Check Details
Selumetinib receives EU approval to treat plexiform neurofibromas in adults caused by NF1 gene mutations
2026-02-01 22:25:32
Check Details
How long does it take for resistance to Lorlatinib/Lorlatinib (Borina) to develop?
2026-02-01 22:25:32
Check Details
The efficacy of cabozantinib in lung cancer
2026-02-01 22:25:32
Check Details
Which genes does Bosutinib target?
2026-02-01 22:25:32
Check Details
Garadacimab-ANDEMBRY instruction manual in Chinese
2026-02-01 22:25:32
Check Details
How effective is Nintedanib/Vigat in the treatment of pulmonary fibrosis?
2026-02-01 22:25:32
Check Details
1
2
...
2180
2181
2182
2183
2184
2185
2186
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib Medication Management Guide for Special Populations
2
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
3
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
4
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
5
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
6
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
7
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
8
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
9
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
10
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management